Securities

Too big to fail – Spring semester business law students learned how the rise and fall of railroads pioneered a path to deal with large-scale corporate bankruptcies

by

June 17, 2024
Douglas Sasso (LAW ’26) shares a spotlight on a Spring 2024 Current Topics in Business Law course which covered the influence railroads had on the development of the American legal system. Focusing on the Penn Central bankruptcy, the course offered students a chance to study what was once the largest merger and bankruptcy in history and its affect on legal, regulatory, and economic systems.

Defense Bar Commentary Highlights Practice Points for Biotech Securities Litigation

by

A panel of corporate advisors updated their 2017 survey of securities litigation involving development-stage biotech companies, providing important practice points for the institutional investor and concluding that biotech start-ups do not pose a greater securities class action risk compared to other companies. Stronger cases involved plaintiffs making credible allegations that defendants intentionally misrepresented data or facts about their interactions with the FDA, omitted adverse regulator feedback, or presented misleading information about regulatory milestones or assessments.

Securities and Exchange Commission Adopts Final Fund of Funds Rule

by

On October 7, 2020, the Securities and Exchange Commission (SEC) adopted Rule 12d1-4 and other amendments under the Investment Company Act of 1940, as amended, which streamline and enhance the regulatory requirements for registered investment companies and business development companies to acquire shares of other funds in excess of the limits in Section 12(d)(1) of the 1940 Act.